Evidence map›Paper›PMID 18842532›Full record

ArticleClinical journal of oncology nursing2008

Symptom management in hepatocellular carcinoma.

Virginia Chih-Yi Sun, Linda Sarna

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical journal of oncology nursing, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 3 pooled it
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 3 syntheses or guidelines pooled it, 97 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Observational
  7. The Role of miRNA-21 in the Metastasis of Hepatocellular Carcinoma as a Therapeutic Target.International journal of hematology-oncology and stem cell research · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Associations of tumor-related psychiatric symptoms and healthy behaviors with dynamic quality of life after hepatocellular carcinoma hepatectomy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Virginia Chih-Yi SunDepartment of Nursing Research and Education in Division of Population Sciences, City of Hope National Medical Center, Duarte, CA, USA. vsun@coh.org
Linda Sarna
City Of Hope National Medical Center · US

Funding

Vulnerable Populations/Health Disparities ResearchT32NR007077 · NINR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HODGE, FELICIA SCHANCHE · 1994 to 2016
$2.9M
Illness Perception, Pain, and Symptom Distress in Gastrointestinal CancersF31NR011110 · NINR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SUN, VIRGINIA CHIH-YI · 2008 to 2009
$57k
NINR NIH HHS F31 NR011110NINR NIH HHS T32 NR007077
6 · The paper itself

Abstract

Hepatocellular carcinoma (HCC) annually causes about one million deaths. Because of advanced stage at diagnosis, HCC carries a five-year survival rate of less than 5% in patients diagnosed with unresectable disease. Incidence for HCC is higher in men and individuals of Asian descent, where viral hepatitis, a leading cause of HCC, is endemic. This article will provide an overview of the complex symptom management of patients with HCC. The occurrence of multiple symptoms, including pain, fatigue, weight loss, and obstructive syndromes (e.g., ascites, jaundice) in patients with HCC is common. Because of limitations in the efficacy of current treatment options, aggressive symptom management is key to preserving physical functioning and quality of life in patients with HCC. A multidisciplinary team approach to symptom management of patients with HCC is critical, with oncology nurses playing an integral role.

Indexed as

Carcinoma, HepatocellularHumansIncidenceLiver NeoplasmsSurvival Rate

Identifiers

PMID18842532
PMCPMC2881685
OpenAlexW2012975578

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.